On January 8, 2026, TD Cowen analyst Robert Moskow reduced the price objective for The Procter & Gamble Company (NYSE:PG) from $168 to $150, maintaining a buy rating. The adjustment was part of the firm's 2026 consumer staples projection, which anticipates difficulties for large-cap companies in the sector. Volume growth is not expected to rise significantly from -0.9% in 2025, and pricing is projected to remain muted.
Also on January 8, 2026, Texas Attorney General Ken Paxton stated that The Procter & Gamble Company and Crest children's toothpaste had reached an agreement. Under the deal, P&G will ensure that marketing and packaging accurately depict the appropriate amount of fluoride toothpaste for children. The updated packaging took effect on January 1, 2026, and P&G must continue compliance for five years. This settlement follows a similar agreement by the Texas Attorney General's office with Colgate over fluoride representation issues.
The Procter & Gamble Company is one of the world's largest consumer product makers, with annual revenues of approximately $85 billion, according to Morningstar. It was recently listed among seven best beauty stocks to buy.